Dorbala, S; Ando, Y; Bokhari, S; Dispenzieri, A; Falk, RH; Ferrari, VA; Fontana, M; ... Bourque, JM; + view all Dorbala, S; Ando, Y; Bokhari, S; Dispenzieri, A; Falk, RH; Ferrari, VA; Fontana, M; Gheysens, O; Gillmore, JD; Glaudemans, AWJM; Hanna, MA; Hazenberg, BPC; Kristen, AV; Kwong, RY; Maurer, MS; Merlini, G; Miller, EJ; Moon, JC; Murthy, VL; Quarta, CC; Rapezzi, C; Ruberg, FL; Shah, SJ; Slart, RHJA; Verberne, HJ; Bourque, JM; - view fewer (2019) ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 2 of 2—Diagnostic Criteria and Appropriate Utilization. Journal of Cardiac Failure , 25 (11) pp. 854-865. 10.1016/j.cardfail.2019.08.002.

Preview

Text Cardiac Amyloidosis Consensus Statement - Part 2_Final.pdf - Accepted Version Download (582kB) | Preview

Abstract

Cardiac amyloidosis is emerging as an underdiagnosed cause of heart failure and mortality. Growing literature suggests that a noninvasive diagnosis of cardiac amyloidosis is now feasible. However, the diagnostic criteria and utilization of imaging in cardiac amyloidosis are not standardized. In this paper, Part 2 of a series, a panel of international experts from multiple societies define the diagnostic criteria for cardiac amyloidosis and appropriate utilization of echocardiography, cardiovascular magnetic resonance imaging, and radionuclide imaging in the evaluation of patients with known or suspected cardiac amyloidosis.

Download activity - last month

Export as CSVXMLJSON

Download activity - last 12 months

Export as JSONCSVXML

Downloads by country - last 12 months

Export as CSVXMLJSON

Archive Staff Only

View Item